Corporate Mission

TRIN Pharma GmbH develops new small molecule drugs for an effective tumor treatment. Our research is focussed on innovative compounds with a propriatory molecular structure, with high selectivity and potent anti-tumor activity.

TRIN Pharma’s business objective is the development of its molecules into clinical studies and commercialization.